![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Tag: Coronavirus information (COVID-19)
Press Releases
CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals Australian Subsidiary
CEPI, the Coalition for Epidemic Preparedness Innovations, announced a ninth worldwide collaboration to develop a COVID-19 vaccine. CEPI will invest an initial US$3.5 million...
Press Releases
INOVIO Expands Manufacturing of COVID-19 DNAVaccine INO-4800 With New Funding from CEPI
INOVIO announced it has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG,...
News
Applied Biology in Collaboration with University Hospital Ramon y Cajal To Launch a Clinical Study to Identify Genetic Risk to COVID-19 Mortality
In a joint research effort studying the genetics of the androgen receptor in androgenetic alopecia, scientists discover a possible genetic variation that pre-disposes COVID-19...
News
AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand
AMRI announced its ongoing commitment to do its part in support of public health needs amidst the COVID-19 pandemic. The company continues to focus...
News
Vaxart Announces Additional Positive Pre-Clinical Data for its Oral COVID-19 Vaccine Program
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has obtained...
Press Releases
Arcturus Therapeutics and Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc., the leading global provider of advanced delivery...
News
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia
Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced the enrollment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read